FindTrial
Sign In

p53 gene therapy

DRUG3 trials

Sponsors

Shenzhen SiBiono GeneTech Co.,Ltd

Conditions

Advanced Malignant Thyroid TumorsAdvanced Oral and Maxillofacial Malignant TumorsDiabetesHCC

Phase 2

p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma
NCT02561546
Shenzhen SiBiono GeneTech Co.,LtdDiabetes, HCC
Start: 2015-12-31End: 2017-12-31Target: 40Updated: 2015-09-28

Phase 4

rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors
NCT00902122
Shenzhen SiBiono GeneTech Co.,LtdAdvanced Malignant Thyroid Tumors
Start: 2009-05-31End: 2012-08-31Target: 600Updated: 2012-04-09
rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors
NCT00902083
Shenzhen SiBiono GeneTech Co.,LtdAdvanced Oral and Maxillofacial Malignant Tumors
Start: 2009-06-30End: 2012-07-31Target: 600Updated: 2012-04-09